Alexion Pharmaceuticals suffered a GAAP loss of $0.511 billion in 6 months of 2020 against a profit of $1.048 billion the previous year. Revenues increased by 23.3% to $2.889 billion compared to $2.344 billion a year earlier.
Alexion Pharmaceuticals suffered a GAAP loss of $0.511 billion in 6 months of 2020 against a profit of $1.048 billion the previous year. Revenues increased by 23.3% to $2.889 billion compared to $2.344 billion a year earlier. 
ir.alexion.com
English (US) 